MedicineNet.com
About Us | Privacy Policy | Site Map
November 25, 2009
MedicineNet home Picture Slideshows Diseases and conditions Symptoms and signs Procedures and tests Medications Health and Living Picture Image Collection MedTerms medical dictionary
Font Size
A
A
A
Disclaimer


valrubicin-intravesical (cont.)

PRECAUTIONS: Tell your doctor your medical history, especially of: irritable bladder, bladder spasms, small bladder size or other bladder problems (e.g., perforation, trauma), urinary tract infections, allergies (especially to anthracyclines such as daunorubicin or doxorubicin, and allergy to polyoxyethyleneglycol which is also known as Cremophor EL). This medication is not recommended for use during pregnancy. Consult your doctor for more details. It is not known whether this drug passes into breast milk. Because of the potential risk to the infant, breast-feeding while using this drug is not recommended. Consult your doctor before breast-feeding.

DRUG INTERACTIONS: Tell your doctor of all prescription and nonprescription medication you may use, especially of: other anti- cancer drugs. Do not start or stop any medicine without doctor or pharmacist approval.

OVERDOSE: If overdose is suspected, contact your local poison control center or emergency room immediately. US residents can call the US national poison hotline at 1-800-222-1222. Canadian residents should call their local poison control center directly. This medicine may be harmful if swallowed.

NOTES: Do not share this medication with others. Laboratory and/or medical tests (e.g., biopsy, cystoscopy, urine cytology) will be performed to monitor your progress.

MISSED DOSE: If you miss a dose, contact your doctor or pharmacist to establish a new dosing schedule.

STORAGE: Before mixing, store the solution between 36 and 45 degrees F (2-8 degrees C). Do not freeze or heat the vials. After dilution in IV fluids, valrubicin is stable for 12 hours at temperatures up to 77 degrees F (25 degrees C).

MEDICAL ALERT: Your condition can cause complications in a medical emergency. For enrollment information call MedicAlert at 1-800-854-1166 (USA), or 1-800-668-1507 (Canada).


Last Editorial Review: 3/2/2005




Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Printer-Friendly Format  |  Email to a Friend


Suggested Reading by Our Doctors
MedicineNet Doctors
  • Cancer - Learn about cancer types, disease statistics, facts, and survival rates, and get information about how malignant tumors (cancerous growths) metastasize or spread.
  • Bladder Cancer - Get information on bladder cancer causes, risks (smoking), symptoms, signs, staging, treatment (chemotherapy, surgery [cystectomy]), diagnosis and tumor types.

Latest Medical News


Back to Medications Index

copyright


Women's Health

Find out what women really need.


Are you Depressed? Take the Quiz

Your Guide to Symptoms & Signs: Pinpoint Your Pain





Top 2
valrubicin-intravesical, Valstar Related Articles







Health categories:

Slideshows | Diseases & Conditions | Symptoms & Signs | Procedures & Tests | Medications | Health & Living | News & Views | Medical Dictionary

Popular health centers:

Allergies | Arthritis | Cancer | Diabetes | Digestion | Healthy Kids | Heart | Men's Health | Mental Health | Women's Health | More...

Publications:

ePublications (PDFs) | XML News via RSS | Audio Podcasts | Email Newsletters

MedicineNet.com:

About Us | Privacy Policy | Site Map | WebMD® | Medscape® | eMedicine® | eMedicineHealth® | RxList®

This website is certified by Health On the Net Foundation. Click to verify. This site complies to the HONcode standard for trustworthy health information:
verify here.

©1996-2009 MedicineNet, Inc. All rights reserved. Notices and Legal Disclaimer.
MedicineNet does not provide medical advice, diagnosis or treatment. See additional information.